The effect of supplementation with cornelian cherry on different cardiometabolic outcomes

FHS
July 11, 2024
12:06 pm

A recent meta-analysis in Nutrients examined recent studies on the cornelian cherry, Cornus mas L., for evidence of its cardiometabolic benefit.

The Role of AI-Enabled Pathology in Enhancing Patient Care

Joseph Mossel, Ibex Medical Analytics’ CEO There’s no doubt that cancer screening, early detection, and swift intervention are invaluable for improving patients’ health outcomes. In

December 9, 2024

Novaliq’s dry eye disease therapy receives US FDA approval

Novaliq’s VEVYE (cyclosporine ophthalmic solution) 0.1% is indicated to treat the signs and symptoms of dry eye disease. Credit: megaflopp via Shutterstock.com. Biopharmaceutical company Novaliq

June 9, 2023

Key genetic factors linked to severe cholera symptoms discovered

Experts have used a cutting-edge computational approach to discover the genetic factors that make the bacteria behind cholera so dangerous – which could be key

September 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.